Top Markets
#1 Siacoin Siacoin +29.48%
#2 Official Trump Official Trump +25.53%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +19.32%
#4 EXOD EXOD +18.93%
#5 MowCat MowCat +18.23%
#6 Unit Pump Unit Pump +16.28%
#7 Pump.fun Pump.fun +16.28%
#8 Melania Meme Melania Meme +15.60%
#9 Mubarak Mubarak +14.72%
#10 Wrapped POL Wrapped POL +13.16%
Coin of the day
Siacoin Siacoin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
Rang in Aktien #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
Aktienkurs
$1.81
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$77.00M
Veränderung (1 Tag)
1.30%
Veränderung (1 Jahr)
-23.63%
Land
US
Handel Annovis Bio, Inc. (ANVS)

Kategorie

Healthcare
EPS für Annovis Bio, Inc. (ANVS)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Annovis Bio, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Annovis Bio, Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH